The groundbreaking therapy of the medication represents a significant development in the care of type 2 diabetes. Unlike existing drugs, tirzepatide impacts two pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatidepeptide915135.blogstival.com/63647048/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment